| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 01, 2024 | Sale | $7.73 | 50,000 | 386,500 | 863,524 | May 03, 2024, 06:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 02, 2024 | Sale | $8.47 | 50,000 | 423,500 | 834,820 | May 03, 2024, 06:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 03, 2024 | Sale | $8.84 | 40,000 | 353,600 | 978,524 | Apr 05, 2024, 05:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 03, 2024 | Sale | $8.84 | 25,000 | 221,000 | 0 | Apr 05, 2024, 05:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 04, 2024 | Sale | $9.02 | 40,000 | 360,800 | 938,524 | Apr 05, 2024, 05:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 04, 2024 | Sale | $9.02 | 25,000 | 225,500 | 0 | Apr 05, 2024, 05:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 28, 2024 | Sale | $10.10 | 25,000 | 252,500 | 0 | Apr 01, 2024, 06:40 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 28, 2024 | Sale | $10.10 | 40,000 | 404,000 | 1,043,524 | Apr 01, 2024, 06:40 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Option Exercise | $4.42 | 39,924 | 176,384 | 1,144,843 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Sale | $11.86 | 36,319 | 430,682 | 1,108,524 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Sale | $11.56 | 1,000 | 11,562 | 0 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Sale | $11.56 | 4,000 | 46,259 | 0 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 06, 2024 | Sale | $11.55 | 20,000 | 231,002 | 0 | Mar 08, 2024, 07:08 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 15, 2024 | Option Exercise | $12.43 | 11,148 | 138,570 | 1,104,919 | Feb 16, 2024, 07:57 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 09, 2024 | Option Exercise | $10.09 | 3,233 | 32,621 | 1,116,067 | Feb 13, 2024, 06:55 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 07, 2024 | Option Exercise | $2.48 | 31,250 | 77,500 | 822,975 | Feb 09, 2024, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 07, 2024 | Sale | $9.22 | 48,272 | 444,981 | 774,703 | Feb 09, 2024, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Sale | $9.51 | 20,000 | 190,240 | 0 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Option Exercise | $2.48 | 31,250 | 77,500 | 822,578 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Sale | $9.49 | 30,853 | 292,804 | 791,725 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Sale | $9.49 | 1,000 | 9,494 | 0 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 03, 2024 | Sale | $9.51 | 4,000 | 38,029 | 0 | Jan 05, 2024, 08:03 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 06, 2023 | Sale | $7.49 | 59,829 | 448,394 | 791,328 | Dec 08, 2023, 05:22 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 06, 2023 | Option Exercise | $2.48 | 31,250 | 77,500 | 851,157 | Dec 08, 2023, 05:22 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 15, 2023 | Option Exercise | $7.18 | 16,913 | 121,435 | 819,907 | Nov 17, 2023, 05:50 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Sale | $5.20 | 37,177 | 193,306 | 836,820 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Sale | $5.14 | 1,000 | 5,137 | 0 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Sale | $5.14 | 4,000 | 20,564 | 0 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Sale | $5.11 | 20,000 | 102,294 | 0 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 01, 2023 | Option Exercise | $2.48 | 31,250 | 77,500 | 873,997 | Nov 03, 2023, 06:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 04, 2023 | Option Exercise | $2.48 | 31,250 | 77,500 | 902,541 | Oct 06, 2023, 06:12 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 04, 2023 | Sale | $7.21 | 59,794 | 431,025 | 842,747 | Oct 06, 2023, 06:12 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Sale | $8.83 | 4,000 | 35,335 | 0 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Sale | $8.83 | 20,000 | 176,696 | 0 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Option Exercise | $2.48 | 31,250 | 77,500 | 905,056 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Sale | $8.78 | 33,765 | 296,575 | 871,291 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 06, 2023 | Sale | $8.84 | 1,000 | 8,836 | 0 | Sep 08, 2023, 05:01 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 15, 2023 | Option Exercise | $9.19 | 16,913 | 155,430 | 873,806 | Aug 17, 2023, 06:40 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 02, 2023 | Sale | $13.04 | 65,015 | 847,712 | 894,779 | Aug 04, 2023, 05:51 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 02, 2023 | Option Exercise | $4.42 | 39,924 | 176,384 | 955,734 | Aug 04, 2023, 05:51 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Sale | $13.14 | 31,818 | 417,976 | 944,205 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Sale | $11.83 | 1,000 | 11,828 | 764 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Sale | $11.79 | 4,000 | 47,172 | 3,150 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Sale | $11.76 | 20,000 | 235,266 | 15,570 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jul 12, 2023 | Option Exercise | $2.48 | 31,250 | 77,500 | 947,628 | Jul 14, 2023, 06:52 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 07, 2023 | Option Exercise | $2.48 | 31,250 | 77,500 | 972,814 | Jun 09, 2023, 05:12 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jun 07, 2023 | Sale | $9.05 | 56,436 | 510,808 | 916,378 | Jun 09, 2023, 05:12 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 15, 2023 | Option Exercise | $5.60 | 11,661 | 65,302 | 941,564 | May 17, 2023, 06:16 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Sale | $4.90 | 20,000 | 98,036 | 0 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Option Exercise | $2.48 | 31,250 | 77,500 | 986,298 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Sale | $4.71 | 33,073 | 155,761 | 953,225 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Sale | $4.92 | 1,000 | 4,915 | 0 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | May 03, 2023 | Sale | $4.91 | 4,000 | 19,623 | 0 | May 05, 2023, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2022 | Sale | $7.39 | 18,500 | 136,669 | 582,805 | Apr 28, 2023, 04:32 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 06, 2023 | Sale | $6.64 | 40,000 | 265,672 | 906,710 | Apr 07, 2023, 05:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 05, 2023 | Option Exercise | $2.48 | 31,250 | 77,500 | 960,037 | Apr 07, 2023, 05:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Apr 05, 2023 | Sale | $6.46 | 13,327 | 86,038 | 946,710 | Apr 07, 2023, 05:30 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Sale | $8.09 | 4,000 | 32,362 | 0 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Sale | $8.10 | 20,000 | 161,900 | 0 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 09, 2023 | Sale | $7.77 | 15,000 | 116,621 | 938,787 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Option Exercise | $2.48 | 93,750 | 232,500 | 1,034,677 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Sale | $8.10 | 70,890 | 573,925 | 963,787 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 08, 2023 | Sale | $8.09 | 1,000 | 8,087 | 0 | Mar 10, 2023, 05:34 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 02, 2023 | Sale | $7.90 | 500 | 3,952 | 0 | Mar 06, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 02, 2023 | Sale | $7.91 | 1,000 | 7,906 | 0 | Mar 06, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 02, 2023 | Sale | $7.92 | 18,500 | 146,502 | 940,927 | Mar 06, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Mar 02, 2023 | Sale | $7.91 | 1,000 | 7,909 | 0 | Mar 06, 2023, 06:07 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 15, 2023 | Option Exercise | $8.44 | 1,346 | 11,360 | 940,927 | Feb 17, 2023, 05:14 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 02, 2023 | Sale | $9.20 | 1,000 | 9,202 | 0 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 02, 2023 | Sale | $9.21 | 500 | 4,604 | 0 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 02, 2023 | Sale | $9.21 | 1,000 | 9,208 | 0 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 01, 2023 | Option Exercise | $8.55 | 1,382 | 11,816 | 942,273 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Feb 02, 2023 | Sale | $9.22 | 18,500 | 170,548 | 942,273 | Feb 03, 2023, 05:11 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.38 | 1,000 | 7,382 | 0 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.38 | 500 | 3,689 | 0 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.39 | 1,000 | 7,391 | 0 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Jan 05, 2023 | Sale | $7.39 | 18,500 | 136,669 | 525,805 | Jan 06, 2023, 06:28 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.02 | 37,210 | 335,760 | 582,805 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.28 | 1,000 | 9,277 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.26 | 500 | 4,632 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Sale | $9.28 | 1,000 | 9,277 | 0 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Dec 01, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 601,515 | Dec 02, 2022, 06:17 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 15, 2022 | Option Exercise | $11.86 | 5,751 | 68,207 | 570,265 | Nov 17, 2022, 06:44 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.00 | 36,693 | 366,947 | 576,016 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.10 | 1,000 | 10,099 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.11 | 500 | 5,055 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Sale | $10.10 | 1,000 | 10,098 | 0 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Nov 03, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 594,209 | Nov 04, 2022, 06:39 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.58 | 36,053 | 417,468 | 562,959 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 1,000 | 11,641 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 500 | 5,821 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Sale | $11.64 | 1,000 | 11,643 | 0 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Oct 06, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 580,512 | Oct 07, 2022, 07:19 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.34 | 36,566 | 377,944 | 549,262 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 1,000 | 10,504 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 500 | 5,249 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Sale | $10.50 | 1,000 | 10,502 | 0 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Sep 01, 2022 | Option Exercise | $2.48 | 31,250 | 77,500 | 567,328 | Sep 02, 2022, 07:24 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 15, 2022 | Option Exercise | $12.96 | 5,751 | 74,533 | 536,078 | Aug 17, 2022, 06:32 PM | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer | Aug 04, 2022 | Sale | $9.45 | 1,000 | 9,447 | 0 | Aug 05, 2022, 07:34 PM |
Menu